Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Phosphorus containing other than solely as part of an...
Patent
1994-11-15
1997-04-08
Tsang, Cecilia
Drug, bio-affecting and body treating compositions
Designated organic active ingredient containing
Phosphorus containing other than solely as part of an...
546 23, 536 265, 514656, 424468, 558 89, A61K 31675, A61K 31135, C07F 906, C07H 1904
Patent
active
056188030
ABSTRACT:
The invention provides compounds of the formula ##STR1## or a pharmaceutically acceptable salt thereof, wherein [D] is the residue of a drug having a reactive functional group, said functional group being attached, directly or through a bridging group, via an oxygen-phosphorus bond to the phosphorus atom of the ##STR2## moiety; R.sub.1 is C.sub.1 -C.sub.8 alkyl, C.sub.6 -C.sub.10 aryl or C.sub.7 -C.sub.12 aralkyl; R.sub.2 is hydrogen, C.sub.1 -C.sub.8 alkyl, C.sub.6 -C.sub.10 aryl, C.sub.4 -C.sub.9 heteroaryl, C.sub.3 -C.sub.7 cycloalkyl, C.sub.3 -C.sub.7 cycloheteroalkyl or C.sub.7 -C.sub.12 aralkyl; and R.sub.3 is selected from the group consisting of C.sub.1 -C.sub.8 alkyl; C.sub.2 -C.sub.8 alkenyl having one or two double bonds; (C.sub.3 -C.sub.7 cycloalkyl)-C.sub.r H.sub.2r -- wherein r is zero, one, two or three, the cycloalkyl portion being unsubstituted or bearing 1 or 2 C.sub.1 -C.sub.4 alkyl substituents on the ring portion; (C.sub.6 -C.sub.10 aryloxy)C.sub.1 -C.sub.8 alkyl; 2-, 3- or 4-pyridyl; and phenyl-C.sub.r H.sub.2r -- wherein r is zero, one, two or three and phenyl is unsubstituted, or is substituted by 1 to 3 alkyl each having 1 to 4 carbon atoms, alkoxy having 1 to 4 carbon atoms, halo, trifluoromethyl, dialkylamino having 2 to 8 carbon atoms or alkanoylamino having 2 to 6 carbon atoms. The compounds are adapted for targeted drug delivery, especially to the brain.
REFERENCES:
patent: 3929840 (1975-12-01), Christensen et al.
patent: 4540564 (1985-09-01), Bodor
patent: 4670422 (1987-06-01), Karanewsky et al.
patent: 4686298 (1987-08-01), Karanewsky et al.
patent: 4703043 (1987-10-01), Karanewsky et al.
patent: 4808813 (1989-02-01), Joshi et al.
patent: 4816570 (1989-03-01), Farquhar
patent: 4968788 (1990-11-01), Farquhar
patent: 5049553 (1991-09-01), Sudilovsky
patent: 5093129 (1992-03-01), Horovitz et al.
patent: 5155100 (1992-10-01), Erion et al.
patent: 5232920 (1993-08-01), Neustadt
Kirchner et al., J. Org. Chem. (1949), p. 388.
Farquhar et al., J. Pharm. Sci., vol. 72, No. 3, Mar. 1983, 324-325.
Srivastva et al., Bioorganic Chemistry 12 (1984), 118-129.
Prisbe et al., J. Med. Chem., 1986, 29, 671-675.
Mitsuya et al, Science, vol. 249, 28 Sep. 1990, 1533-1543.
Iyer et la., Tetrahedron Letters,vol. 30, No. 51, 1989, pp. 7141-7144.
Chemical Abstracts, vol. 112, 1990, abstract No. 69487n.
Tsang Cecilia
University of Florida
LandOfFree
Targeted drug delivery via phosphonate derivatives does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Targeted drug delivery via phosphonate derivatives, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Targeted drug delivery via phosphonate derivatives will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-2397807